Investment Q&A

Q: With the recent decline of CSW and VLN, do you see them has a good entry from a growth perspective? Thanks!

Q: Have a 3% position @ $1.93 p/p.Add,hold or sell?Txs for u usual great services & views

Q: Please comment on why the market was disappointed in today's earnings and outlook. Thanks

Q: About to sell this real loser, however I do respect & appreciate your opinion. Have owned it for nearly 3 yrs & while rising slightly at one point during a momentary pop-up in Jan-Feb of this year, it has now dropped 25%. Before dumping, I thought you might have a contrarian position as its book V is nearly $8.50. Thank you.

Q: Is RHT the new PHM? It seems it was heavily promoted, pump-ed up above 2$ , the smart money left, while the dumb money are left to lick their losses. It's basically in free fall every day.

Q: is it a good time to add to rht to bring it back up to a 3 % position

Q: Hi Team, recently a guest on BNN had Acasti Pharma as a top pick. He mentioned that the price could double by year's end and could reach the $10 mark by next year. Your thoughts on this company please. Thank-you in advance. Sam

Q: May I have your comments please on EIL. I have held it for several years and have lost some money on it. Shall I move on?

John

Q: Hi,
I had PLI in my TFSA as of yesterday. I sold it at an 80% loss. Is there any one good growth company that I can replace it with that would regain my losses? It's the only stock in my TFSA and it's a small position.
Thanks

Q: what do you think of the earnings this morning. is there a future here. does it have enough cash to keep going. thanks bill

Q: Could yo please comment on the Q4 results please. The market does not appear to like them. Thank you, Ian

Q: Hello 5i Team,
I'm curious on what your thoughts were regarding these two overlooked companies. If they do not interest you would you have any recommendation for small technology companies and/or diversified alternate asset management company?

Thank you!

Q: Gentlemen: Would you recommend SVI as a good investment for my RRIF over a period of 5 years? Do you feel they have too much debt?
Thank you
Ken Beatty

Q: 5I Team,

Can I please get your thoughts on Venzee Technologies Inc. V.VENZ

Thank you

Q: BLN recently announced Q1 revenue increased 51%,& loss of 0.5 which beat expectations. Your thoughts on the results & going forward,Is it ok to buy some?Txs for u usual great services & views

Q: Thank you 5i for helping me realize it is time to refocus my investment philosophy.
Ignorance is bliss. In more recent times, my bliss has turned to self scrutiny full responsibility for my investment decisions. Thus I signed up with 5i because what I see offered is good common advice, not hopeful returns.

About a year ago I was in a blissful state and followed some advice to invest in these companies as potential Canadian 10+ baggers: TSO3 INC, CRH MEDICAL, SUNOPTA, EXCO TECHNOLOGIES, PIZZA PIZZA ROYALTY CORP, MEDICAL FACILITIES, MAJOR DRILLING GRP INTL, WESTAIM CORP, CORBY SPIRIT & WINE-A, TRICON CAPITAL, and AUTOMOTIVE PPTY REIT
Consequently, I invested about 5% of my total portfolio in the hopes of winners. One year later all are down 10% or more with a combined loss on paper, ytd, of almost 20%.
Thankfully, the majority of my stock investments are in ETFs. I am not opposed to owning individual stocks. Based on your views of these companies, should I sell off all or any of these and make some wiser, less speculative choices? Any other sage advice would also be welcomed.

Q: Hello,
I have another (very) small cap stock question.
Do you have any information on Pascal? Seems interesting from a couple of perspectives.

From their website: "However, Pascal is the first to identify a mechanism in which cannabinoids may provide a direct benefit in immunotherapy."

Thanks!

Brian

Q: I noticed that QST had a one time impairment charge of $0.04 per share in Q4. If you add that back that to Q4 results, isn't QST's stock undervalued today based on its growth profile, current revenue run rate plus that the Company stated (in its earnings press release) that its revenue growth is sustainable?

Q: Following up on the comments on year end numbers, without the one time charge the earnings were actually ahead of estimates at 18 cents for the year vs. 17 cents estimated.

Q: If not asked already, comments please on QST results released today and what it might mean going forward. They seem strong across the board.